Safety and effectiveness of fascial therapy in adult patients with hemophilic arthropathy. A pilot study

Donoso-Úbeda, Elena; Meroño-Gallut, Javier; López‐Pina, José Antonio; Cuesta‐Barriuso, Rubén

doi:10.1080/09593985.2018.1425513

Cited by 20 publications

(32 citation statements)

References 29 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…According to our clinical experiences and our review of the literature, we believe that physiotherapy is safe for haemophilia patients, and the probability of new haemorrhage induced by physiotherapy is very low in haemophilia patients.…”

Section: Discussionmentioning

confidence: 92%

Survey of non‐physiotherapy department medical staff in China and their understanding of physiotherapy in comprehensive management of haemophilia

Liu

Zhao

et al. 2019

Haemophilia

View full text Add to dashboard Cite

Introduction Physiotherapy plays a very important role in comprehensive care of patients with haemophilia. Due to limited resources and a lack of understanding among medical personnel, physiotherapy has not become a standard component of comprehensive management of haemophilia in China. Aim To investigate the understanding and practice of physiotherapy in the comprehensive management of haemophilia by non‐physiotherapy department medical staff engaged in haemophilia work in China. Methods A specifically designed questionnaire was used to investigate the medical staff who participated in the 10th World Federation of Hemophilia—Hemophilia Conference China held in Xi'an, China, from 14 October to 16 October 2016. Results Among all respondents, 97.2% believed that haemophilia patients needed physiotherapy. However, only 17.5% of the respondents were found to have a very accurate understanding of the timing of physiotherapeutic interventions for haemophilia patients; 83.9% of the respondents worried that physiotherapy would increase the incidence of new haemorrhagic episodes in haemophilia patients, and 11.1% of the respondents never recommended physiotherapy for haemophilia patients. Factors that independently affected the respondents’ knowledge of the timing of physiotherapy in haemophilia patients were their professional rank and participation in continuing education that included haemophilia physiotherapy. One factor that independently affected respondents’ recommendation of physiotherapy to patients was participation in continuing education that included haemophilia physiotherapy. Conclusion Haemophilia continuing education covering physiotherapy should be strengthened for new non‐physiotherapy medical staff in the haemophilia field.

show abstract

Section: Discussionmentioning

confidence: 92%

Survey of non‐physiotherapy department medical staff in China and their understanding of physiotherapy in comprehensive management of haemophilia

Liu

Zhao

et al. 2019

Haemophilia

View full text Add to dashboard Cite

show abstract

“…Therefore, this intermediate dose of prophylaxis would not maintain haemarthropathy below the critical level for most of these patients' lifetimes; thus, additional measures, such as rehabilitation therapy and orthopaedic surgery, may be needed to enhance their QoL. [18][19][20] In conclusion, the reported intermediate-dose prophylaxis for patients with SHA at our HTC in Korea would maintain haemarthropathy in these patients below the critical level for most of their lifetime when started prior adolescence. However, this would not be achieved in some adolescent patients with rapid progression of haemarthropathy and in most adult patients.…”

Section: Discussion and Con Clus I Onmentioning

confidence: 86%

“…Furthermore, it would take only 8.59 and 43.21 years to reach the average and +2SD of the value of critical haemarthropathy (P‐score, 15.7), respectively, if the annual P‐score increase was the average value in this group (△P′/y, 0.078). Therefore, this intermediate dose of prophylaxis would not maintain haemarthropathy below the critical level for most of these patients’ lifetimes; thus, additional measures, such as rehabilitation therapy and orthopaedic surgery, may be needed to enhance their QoL …”

Section: Discussionmentioning

confidence: 99%

Impact of intermediate‐dose prophylaxis on progression of haemarthropathy in patients with severe haemophilia A: A 10‐year, single‐centre experience in Korea

et al. 2018

View full text Add to dashboard Cite

Aim To determine the impact of 10‐year intermediate‐dose prophylaxis on haemarthropathy progression in patients with severe haemophilia A (SHA). Methods Prophylactic treatment with intermediate dose was given maximally for 10 years to 42 patients with SHA in a haemophilia treatment centre in Korea. Patients were divided into three groups based on prophylactic treatment started age: 1‐10 (group A’), 11‐20 (group B’), and ≥21 (group C’). Average annual increase of Pettersson score (P‐score) was compared between the treatment groups. Results Average ages and P‐scores at initiation of prophylaxis were 4.65±3.43 years and 2.09±3.25, 16.13±1.73 years and 7.37±4.38, and 28.33±7.25 years and 12.33±6.50 for groups A’, B’, and C’. Average annual increase of P‐score in groups A’, B’, and C’ was 0.039±0.11, 0.063±0.123, and 0.078±0.124. Assuming that intermediate‐dose prophylaxis started at the average age, P‐score and annual increase of P‐score would be the average values of each group; it would thus take 210 and 46.5 years to reach –2SD of the average critical level of haemarthropathy (The level of haemarthropathy (P‐score 13.0 ± 2.7) above which there is a significant impact on quality of life in Korean) in groups A’ and B’. However, it would take 55 and 15.75 years if the annual P‐score increase were +2SD of the average value in groups A’ and B’. Conclusion Intermediate‐dose prophylaxis for patients with SHA in Korea would maintain arthropathy below the critical level for most of the patients’ lifetime when started before adolescence. However, this would not be achieved in some adolescent patients with rapid progression of arthropathy and in most adult patients.

show abstract

“…There is reasonable evidence emerging that exercise via its effect on pain, joint range of motion (ROM), strength and mobility can have a positive impact on maximizing mobility and function, behaviour and quality of life in PWH . Similarly, manual therapy—controlled use of manual force applied to articular and soft‐tissue structures through mobilization and stretching to improve biomechanical elasticity—shows some potential benefit, particularly on pain . Unfortunately, studies demonstrating promising results often used/were based on heterogeneous cohorts, few and low powered.…”

Section: Discussion and Recommendationsmentioning

confidence: 99%

“…[22][23][24][25] Similarly, manual therapy-controlled use of manual force applied to articular and soft-tissue structures through mobilization and stretching to improve biomechanical elasticity-shows some potential benefit, particularly on pain. [26][27][28][29][30] Unfortunately, studies demonstrating promising results often used\were based on heterogeneous cohorts, few and low powered. Due to small numbers of studies and diversity of outcomes, meta-analysis and confirmation of efficacy has yet to be reported.…”

Section: Discussion and Recommendationsmentioning

confidence: 99%

Scope of practice of haemophilia physiotherapists: A European survey

et al. 2019

View full text Add to dashboard Cite

Introduction European guidelines on the care of haemophilia recommend ready access to a range of services provided by a multidisciplinary team of specialists including physiotherapy. However, the scope of physiotherapy provided is unknown. Methods The Physiotherapists Committee of the European Association for Haemophilia and Allied Disorders (EAHAD) conducted a web‐based survey to quantify the role and scope of practice of physiotherapists involved in haemophilia care. The survey was sent to more than 200 physiotherapists registered on the EAHAD database. Questions concerned their work practices including assessment and treatment activities and level of autonomy. Results Eighty physiotherapists from twenty‐four European countries responded. Considerable heterogeneity exists in roles, responsibilities, and clinical practice of physiotherapists, particularly in access to and type of physiotherapy treatment provided, as well as the skill set and autonomy of physiotherapists to make independent assessment and treatment decisions. Discussion This pan‐European survey establishes a context to support physiotherapy role development and professional identity. Key recommendations include the following: (a) establishing a pan‐European network to support collaboration and education for physiotherapists working in haemophilia, (b) developing a core skills and capability framework to ensure person‐centred approaches are central as well as working in partnership with those with the condition to maximize early recovery, support self‐management and enablement in remaining active and independent, (c) regular training, standardized validation and maintenance of competency for assessment tools, (d) well‐designed randomized clinical studies with larger numbers of participants from multiple sites should be the focus of future research.

show abstract

Safety and effectiveness of fascial therapy in adult patients with hemophilic arthropathy. A pilot study

Abstract: A physiotherapy program based on fascial therapy is safe in patients with hemophilia. Fascial therapy may improve joint status, pain, and mobility in patients with hemophiliac arthropathy of the knee and ankle.

Cited by 20 publications

References 29 publications

Survey of non‐physiotherapy department medical staff in China and their understanding of physiotherapy in comprehensive management of haemophilia

Survey of non‐physiotherapy department medical staff in China and their understanding of physiotherapy in comprehensive management of haemophilia

Impact of intermediate‐dose prophylaxis on progression of haemarthropathy in patients with severe haemophilia A: A 10‐year, single‐centre experience in Korea

Scope of practice of haemophilia physiotherapists: A European survey

Contact Info

Product

Resources

About